Article
Assessment of hepatocyte growth factor in ovarian cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Aug 2011
Goode Ellen L, Chenevix-Trench Georgia, Hartmann Lynn C, Fridley Brooke L, Kalli Kimberly R, Vierkant Robert A, Larson Melissa C, White Kristin L, Keeney Gary L, Oberg Trynda N, Cunningham Julie M, Beesley Jonathan, Johnatty Sharon E, Chen Xiaoqing, Goodman Katelyn E, Armasu Sebastian M, Rider David N, Sicotte Hugues, Schmidt Michele M, Elliott Elaine A, Høgdall Estrid, Kjær Susanne Krüger, Fasching Peter A, Ekici Arif B, Lambrechts Diether, Despierre Evelyn, Høgdall Claus, Lundvall Lene, Karlan Beth Y, Gross Jenny, Brown Robert, Chien Jeremy, Duggan David J, Tsai Ya-Yu, Phelan Catherine M, Kelemen Linda E, Peethambaram Prema P, Schildkraut Joellen M, Shridhar Vijayalakshmi, Sutphen Rebecca, Couch Fergus J, Sellers Thomas A
Abstract excerpt
BACKGROUND: Invasive ovarian cancer is a significant cause of gynecologic cancer mortality. METHODS: We examined whether this mortality was associated with inherited variation in approximately 170 candidate genes/regions [993 single-nucleotide polymorphisms (SNPs)] in a multistage analysis based initially on 312 Mayo Clinic cases (172 deaths). Additional analyses used The Cancer Genome Atlas (TCGA; 127 cases, 62...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.